INFU

SEC source: 0001014108-19-000157 · primary_doc.xml · nonDerivative · entry 4

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 1,464,916

F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-19-000157 · primary_doc.xml · nonDerivative · entry 3

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 306,402

F2 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-19-000157 · primary_doc.xml · nonDerivative · entry 2

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 1,456,335

F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-19-000152 · primary_doc.xml · nonDerivative · entry 5

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By

Disclosed balance after: 305,737

F2 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-19-000152 · primary_doc.xml · nonDerivative · entry 4

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By

Disclosed balance after: 1,453,007

F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-19-000152 · primary_doc.xml · nonDerivative · entry 3

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By

Disclosed balance after: 303,504

F2 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-19-000152 · primary_doc.xml · nonDerivative · entry 2

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By

Disclosed balance after: 1,441,840

F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-19-000136 · primary_doc.xml · nonDerivative · entry 3

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 301,105

F2 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-19-000136 · primary_doc.xml · nonDerivative · entry 2

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 1,429,847

F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001535264-19-000052 · primary_doc.xml · nonDerivative · entry 1

AWM Investment Company, Inc. · CIK 0001535264 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Limited Partnership

Disclosed balance after: 2,000,000

F2 · shares: AWM Investment Company, Inc., a Delaware corporation (AWM), is the investment adviser to Special Situations Life Sciences Fund, L.P. (LS), (LS, the Fund). As the investment adviser to the Fund, AWM holds sole voting and investment power over 2,000,000 shares of Common Stock of the Issuer (the Shares) held by LS. Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM. The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F1 · price: This is a weighted average price.

F2 · balance_after: AWM Investment Company, Inc., a Delaware corporation (AWM), is the investment adviser to Special Situations Life Sciences Fund, L.P. (LS), (LS, the Fund). As the investment adviser to the Fund, AWM holds sole voting and investment power over 2,000,000 shares of Common Stock of the Issuer (the Shares) held by LS. Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM. The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2 · ownership.direct: AWM Investment Company, Inc., a Delaware corporation (AWM), is the investment adviser to Special Situations Life Sciences Fund, L.P. (LS), (LS, the Fund). As the investment adviser to the Fund, AWM holds sole voting and investment power over 2,000,000 shares of Common Stock of the Issuer (the Shares) held by LS. Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM. The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2 · ownership.nature: AWM Investment Company, Inc., a Delaware corporation (AWM), is the investment adviser to Special Situations Life Sciences Fund, L.P. (LS), (LS, the Fund). As the investment adviser to the Fund, AWM holds sole voting and investment power over 2,000,000 shares of Common Stock of the Issuer (the Shares) held by LS. Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM. The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001445866-19-000723 · form4.xml · nonDerivative · entry 3

Shuda Scott · CIK 0001486636 · Director · 10% owner

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,521,517

F4 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

F3 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP.

SEC source: 0001445866-19-000723 · form4.xml · nonDerivative · entry 2

Shuda Scott · CIK 0001486636 · Director · 10% owner

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,520,394

F4 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

F2 · ownership.direct: These securities are owned by Scott Shuda.

SEC source: 0001445866-19-000723 · form4.xml · nonDerivative · entry 1

Shuda Scott · CIK 0001486636 · Director · 10% owner

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,517,894

F4 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

F1 · ownership.direct: These securities are owned by Meridian TSV II, LP

SEC source: 0001437749-19-010182 · rdgdoc.xml · derivative · entry 1

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2024-05-15

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve equal monthly installments beginning on June 15, 2019.

SEC source: 0001437749-19-010171 · rdgdoc.xml · derivative · entry 1

GENDRON PAUL ANDREW · CIK 0001769450 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2024-05-15

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve equal monthly installments beginning on June 15, 2019.

SEC source: 0001437749-19-010359 · rdgdoc.xml · derivative · entry 1

Sheehan Jeannine · CIK 0001775188 · CHIEF ADMINISTRATIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2029-05-15

F1 · derivative.exercise_date: Stock option vests 33% per year on anniversary date starting May 15, 2020.

SEC source: 0001437749-19-010366 · rdgdoc.xml · derivative · entry 1

Schulte Gregory · CIK 0001740199 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2029-05-15

F1 · derivative.exercise_date: Stock option vests 33% per year on anniversary date starting May 15, 2020.

SEC source: 0001437749-19-010304 · rdgdoc.xml · derivative · entry 1

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2024-05-15

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 35,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve equal monthly installments beginning on June 15, 2019.

SEC source: 0001437749-19-010358 · rdgdoc.xml · derivative · entry 1

RUIZ THOMAS MARK · CIK 0001768484 · VP OF SALES AND MARKETING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2029-05-15

F1 · derivative.exercise_date: Stock option vests 33% per year on anniversary date starting May 15, 2020.

SEC source: 0001437749-19-010313 · rdgdoc.xml · derivative · entry 1

Montgomery Darrell B · CIK 0001639250 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2024-05-15

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve equal monthly installments beginning on June 15, 2019.

SEC source: 0001437749-19-010341 · rdgdoc.xml · derivative · entry 1

Whitman Kevin · CIK 0001768114 · VP and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2029-05-15

F1 · derivative.exercise_date: Stock option vests 33% per year on anniversary date starting May 15, 2020.

SEC source: 0001437749-19-010306 · rdgdoc.xml · derivative · entry 1

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2024-05-15

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve equal monthly installments beginning on June 15, 2019.

SEC source: 0001437749-19-008279 · rdgdoc.xml · derivative · entry 1

Sheehan Jeannine · CIK 0001775188 · CHIEF ADMINISTRATIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2024-04-22

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 50,000 shares of InfuSystem Holdings, Inc. common stock, vests annually over three years beginning April 22, 2020.

SEC source: 0001437749-19-006216 · rdgdoc.xml · derivative · entry 5

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 200,000 shares

Expires 2019-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-19-006216 · rdgdoc.xml · nonDerivative · entry 4

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,924

F4 · price: Represents the difference between the number of the Stock Appreciation Rights exercised and the number of shares issued as a result of the exercise.

F5 · price: Represents the withholding of the Issuer's common stock for the tax liability associated with the exercise of the Stock Appreciation Rights granted on November 15, 2017.

SEC source: 0001437749-19-006216 · rdgdoc.xml · nonDerivative · entry 3

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,678

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Represents the acquisition of the Issuer's common stock by reporting person pursuant to the exercise of the Stock Appreciation Rights granted on November 15, 2017.

SEC source: 0001437749-19-006236 · rdgdoc.xml · derivative · entry 3

RUIZ THOMAS MARK · CIK 0001768484 · VP OF SALES AND MARKETING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents the acquisition of the Issuer's common stock by reporting person pursuant to the vesting and settlement of a one remaining portion of the restricted stock units (RSUs) granted on March 11, 2015. Restricted stock units convert into common stock on a one-for-one basis.

F1 · derivative.exercise_date: Represents the acquisition of the Issuer's common stock by reporting person pursuant to the vesting and settlement of a one remaining portion of the restricted stock units (RSUs) granted on March 11, 2015. Restricted stock units convert into common stock on a one-for-one basis.

F1 · derivative.expiration_date: Represents the acquisition of the Issuer's common stock by reporting person pursuant to the vesting and settlement of a one remaining portion of the restricted stock units (RSUs) granted on March 11, 2015. Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001437749-19-006236 · rdgdoc.xml · nonDerivative · entry 2

RUIZ THOMAS MARK · CIK 0001768484 · VP OF SALES AND MARKETING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,836

F2 · price: Represents the withholding of the Issuer's common stock for the tax liability associated with the vesting and settlement of one remaining portion of the restricted stock units (RSUs) granted on March 11, 2015.

SEC source: 0001437749-19-006236 · rdgdoc.xml · nonDerivative · entry 1

RUIZ THOMAS MARK · CIK 0001768484 · VP OF SALES AND MARKETING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,420

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents the acquisition of the Issuer's common stock by reporting person pursuant to the vesting and settlement of a one remaining portion of the restricted stock units (RSUs) granted on March 11, 2015. Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001437749-19-006216 · rdgdoc.xml · derivative · entry 6

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 25,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents the acquisition of the Issuer's common stock by reporting person pursuant to the vesting and settlement of a portion of the restricted stock units (RSUs) granted on August 23, 2018. Restricted stock units convert into common stock on a one-for-one basis.

F1 · derivative.exercise_date: Represents the acquisition of the Issuer's common stock by reporting person pursuant to the vesting and settlement of a portion of the restricted stock units (RSUs) granted on August 23, 2018. Restricted stock units convert into common stock on a one-for-one basis.

F1 · derivative.expiration_date: Represents the acquisition of the Issuer's common stock by reporting person pursuant to the vesting and settlement of a portion of the restricted stock units (RSUs) granted on August 23, 2018. Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001437749-19-006216 · rdgdoc.xml · nonDerivative · entry 2

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,678

F2 · price: Represents the withholding of the Issuer's common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on August 23, 2018.

SEC source: 0001437749-19-006216 · rdgdoc.xml · nonDerivative · entry 1

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,028

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents the acquisition of the Issuer's common stock by reporting person pursuant to the vesting and settlement of a portion of the restricted stock units (RSUs) granted on August 23, 2018. Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001437749-19-005451 · rdgdoc.xml · nonDerivative · entry 2

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,516,794

F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

F2 · ownership.direct: These securities are owned by Imua T Capital Investments, LLC.

SEC source: 0001437749-19-005451 · rdgdoc.xml · nonDerivative · entry 1

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,516,270

F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

F2 · ownership.direct: These securities are owned by Imua T Capital Investments, LLC.

SEC source: 0001437749-19-005236 · rdgdoc.xml · nonDerivative · entry 3

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 298,388

F2 · ownership.nature: The reported securities are directly owned by Sansone Partners(QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001437749-19-005236 · rdgdoc.xml · nonDerivative · entry 2

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 1,416,264

F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001437749-19-004760 · rdgdoc.xml · nonDerivative · entry 1

Dilorio Richard · CIK 0001706994 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,028

F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

F2 · balance_after: Includes 13,735 shares of the Issuer's common stock acquired by reporting person pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"). Such transaction is exempt under Rule 16(b)-3(c).

F3 · balance_after: Includes 14,734 shares of the Issuer's common stock held by reporting person with the Issuer's transfer agent. Such common stock was not previously reported.

SEC source: 0001437749-18-018380 · rdgdoc.xml · derivative · entry 6

DREYER DAVID C · CIK 0001203607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,833 shares

Expires 2018-10-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option, representing the right to purchase a total of 20,833 shares, became exercisable in ten equal monthly installments following the September 17, 2017 date of grant. All vesting ceased upon termination of the reporting person's service as a Director of the Company on July 19, 2018.

F3 · derivative.expiration_date: The reporting person ceased to be a Director of the Company on July 19, 2018. The option expires three months after the date Optionee ceased to be a Director of the Company.

SEC source: 0001437749-18-018380 · rdgdoc.xml · derivative · entry 5

DREYER DAVID C · CIK 0001203607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2018-10-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares, became exercisable in twelve equal monthly installments following the January 18, 2017 date of grant.

F3 · derivative.expiration_date: The reporting person ceased to be a Director of the Company on July 19, 2018. The option expires three months after the date Optionee ceased to be a Director of the Company.

SEC source: 0001437749-18-018380 · rdgdoc.xml · nonDerivative · entry 4

DREYER DAVID C · CIK 0001203607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,965

F1 · shares: Reflects the number of shares surrendered in connection with the cashless exercise and tax withholding obligations for the exercised option.

SEC source: 0001437749-18-018380 · rdgdoc.xml · nonDerivative · entry 3

DREYER DAVID C · CIK 0001203607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,295

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-18-018380 · rdgdoc.xml · nonDerivative · entry 2

DREYER DAVID C · CIK 0001203607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,462

F1 · shares: Reflects the number of shares surrendered in connection with the cashless exercise and tax withholding obligations for the exercised option.

SEC source: 0001437749-18-018380 · rdgdoc.xml · nonDerivative · entry 1

DREYER DAVID C · CIK 0001203607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001445866-18-000928 · form4.xml · nonDerivative · entry 2

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,505,570

SEC source: 0001445866-18-000928 · form4.xml · nonDerivative · entry 1

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,504,666

SEC source: 0001014108-18-000213 · primary_doc.xml · nonDerivative · entry 3

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,483,611

F1 · ownership.nature: These securities are owned by Imua T Capital Investments, LLC. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001014108-18-000213 · primary_doc.xml · nonDerivative · entry 2

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,471,779

F1 · ownership.nature: These securities are owned by Imua T Capital Investments, LLC. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001014108-18-000213 · primary_doc.xml · nonDerivative · entry 1

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,458,370

F1 · ownership.nature: These securities are owned by Imua T Capital Investments, LLC. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001014108-18-000209 · primary_doc.xml · nonDerivative · entry 4

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,442,719

F1 · ownership.nature: These securities are owned by Imua T Capital Investments, LLC. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001014108-18-000209 · primary_doc.xml · nonDerivative · entry 3

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,438,131

F1 · ownership.nature: These securities are owned by Imua T Capital Investments, LLC. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.